Accumulating specialized expertise and efficiently utilizing our human capital are HL Genomics' core strategies for resilience in an increasingly competitive global landscape.
Research Areas
Process Development & CMC Research
Establishing a robust framework for CMC research, process development, and GMP documentation based on decades of accumulated synthesis technology.
Continuous Industrialization R&D via Quality & Process Improvement
Sustaining product competitiveness through continuous R&D, focused on developing novel salt forms and enantiomer APIs with enhanced stability over existing materials.
Continuous Investment in High-Quality API Production
Equipped with advanced production and analytical instrumentation for high-quality API supply, while establishing a rigorous management system for genotoxic and carcinogenic impurities.